Update: Netflix the Sore Tooth in FANG?
As a follow-up to the analysis we posted on July 18th, on 20th December we announced to our subscribers that we had closed our short position on a temporary basis. The decision was two-fold. The share price had fallen materially, in line with our forecasts,…
Netflix the Sore Tooth in FANG?
NETFLIX NASD:NFLX Authored by N.A.S.M. at Sprout8.com Date: 18/7/2018 Current Price: $380 PE Ratio (TTM): 172 Disclosure: Sprout8 analysts have initiated a short position in Netflix at $382.20 Netflix the Sore Tooth in FANG? Short view – heightened headwinds at a time of historical high valuations…
- Infographic: Excellent prognosis: Developments in Colorectal Cancer Testing – What is Likely to Become The Preferred Test For Population Screening (Part 2 of 2)
- Update: Netflix the Sore Tooth in FANG?
- Infographic: Excellent prognosis: A Primer on Cancer Screening – How Early Detection Can Save Lives and Produce Excellent Investment Returns (Part 1 of 2)
- Netflix the Sore Tooth in FANG?
- Life sciences specialist Merchant Opportunities Fund ups stake in Rhythm